This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: National University of Singapore, Sengenics Sdn Bhd. Active years: 2026.
Company Filing History:
1 out of 850 
1 out of 1 Years Active: 2026
Title: Ross Andrew Soo - Innovator in Cancer Diagnostics
Introduction
Ross Andrew Soo is an inventor based in Singapore, SG. He has made significant contributions to the field of cancer diagnostics, particularly in the detection of biomarkers for Non-Small Cell Lung Cancer (NSCLC). Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical diagnostics.
Latest Patent Applications
Ross Andrew Soo's latest patent application is titled "Detection of Biomarkers for Non-Small Cell Lung Cancer." This application describes a method for diagnosing NSCLC from a sample extracted from a subject by testing the sample for the presence of biomarkers. The biomarkers include autoantibodies against XAGE1D, LRRFIP2, and GAGE2C. The application also claims a method of manufacturing a kit and compositions comprising a panel of said antigens or exosomal autoantibodies.
Conclusion
Ross Andrew Soo's innovative approach to cancer diagnostics highlights the importance of research in the medical field. His work has the potential to improve diagnostic methods for Non-Small Cell Lung Cancer, paving the way for better patient outcomes.